Tag: AXO-Lenti-PD
October 25, 2018
Axovant Doses First Patient in Parkinson’s Trial
The drug, AXO-Lenti-PD, was well tolerated and the patient was able to leave the hospital as expected with no side... October 25, 2018
Axovant Announces Dosing of First Patient in Clinical Study of AXO-Lenti-PD
Axovant Sciences (NASDAQ:AXON), a company developing innovative gene therapies for neurologic and neuromuscular diseases, announced dosing of the first patient... June 6, 2018